Skip to content
Clinical ResearchResearch compound

Pregnenolone

A steroid precursor the body also makes, sold as a supplement; its testosterone-raising effect is not proven.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Pregnenolone vial

Related comparisons

Pregnenolone vs DHEA

DETAILED OVERVIEW

What is Pregnenolone?

Pregnenolone is a substance the body makes itself: the first steroid produced from cholesterol, from which the other steroid hormones, such as testosterone and cortisol, are made. In the United States it is sold over the counter as a dietary supplement, and in Europe it is regulated differently from country to country. It is not banned in competitive sport.

Its advertised testosterone-raising effect is not proven: taken by mouth, only about 5–10% of what is taken shows up in the blood, and the liver turns most of the rest into progesterone. Its supported effect is in the brain: it influences signalling between nerve cells, and users report clearer thinking. Only a few small studies have been done in humans, and it does not replace medical hormone treatment after steroid use. In some people it disturbs sleep, and it can cause headache, anxiety and acne. It crosses the placenta, so it cannot be used during pregnancy or breastfeeding; it is also contraindicated with hormone-sensitive cancer.

Mechanism

Raw material for steroid hormones; alters nerve signaling in the brain

Half-life

~30-45 min (parent; serum kinetics highly variable, rapid first-pass conversion)

Onset

Brain effect within 1–3 hours; hormone effect (if any) within 2–7 days

Legal status

US: over-the-counter supplement; varies in Europe; not a banned doping agent

Data console

Lab data

Androgenic:AnabolicN/A (precursor molecule, NOT a standalone androgen – downstream-conversion dependent, Test substrate-loading magnitude marginal)
AR bindingNo primary receptor – endogenous steroidogenesis…
Active half-life~30-45 min parent + serum kinetics highly variable (pregnenolone-sulfate metabolite longer, ~4-6 hours, neurosteroid-active form)
Detection windowPregnenolone NOT WADA-banned; serum assay measurable via sensitive LC-MS/MS 24-48 hours post-dose. Endogenous baseline variability means detection criteria are not standardized.
AromatizationIndirect: steroid precursor → Test → secondary peripheral E2 conversion. Magnitude small (oral first-pass progesterone conversion dominates, downstream Test substrate-loading marginal).
HepatotoxicityLow – endogenous steroid precursor. Long-term high-dose (>50 mg/day chronic 6+ months) hepatic enzyme rise rare-but-documented.

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Neurosteroid CNS effect: insomnia / heightened alertness in some users (GABA-A negative modulation), so evening dosing can worsen sleep in certain individuals.
  • Headache, irritability, anxiety or restlessness in neurosteroid-sensitive individuals, dose-dependent.
  • Mood swings and unwanted downstream hormonal effects (acne, increased sebum) since pregnenolone is a precursor to both androgens and estrogens.
  • Indirect estrogen conversion (peripheral aromatization via downstream testosterone): water retention, nipple sensitivity. Magnitude is small as oral first-pass progesterone conversion dominates.
  • Rare but documented liver enzyme elevation (ALT/AST) with chronic high-dose use (>50 mg/day for 6+ months).
  • Highly variable, often absent effect: due to poor oral bioavailability (~5-10%), many users see no measurable hormonal or subjective benefit.

Contraindications · 6

  • History or presence of hormone-sensitive cancer (prostate, breast): downstream steroid precursor loading poses a theoretical risk.
  • Pregnancy and breastfeeding: pregnenolone crosses the placenta, theoretical effect on fetal HPG axis; theoretical risk also via partner contact.
  • Does NOT replace evidence-based PCT: used as standalone PCT (instead of a SERM/HCG) in fully suppressed post-cycle state, axis recovery is undocumented.
  • Pre-existing liver disease or elevated baseline ALT/AST: chronic high-dose use may worsen liver function.
  • Concurrent GABAergic / anxiolytic medications (benzodiazepines, SSRIs): theoretical GABA-A negative-modulator antagonism, clinical relevance unclear, caution warranted.
  • Unknown, uncontrolled hormonal disorder: due to the broad downstream steroid spectrum (testosterone, DHEA, cortisol, estrogen), not advised without medical supervision.

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Pregnenolone?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.